B. Riley Wealth Advisors’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,624
Closed -$16.7K 1311
2024
Q3
$16.7K Sell
1,624
-87
-5% -$893 ﹤0.01% 1253
2024
Q2
$15.9K Buy
1,711
+165
+11% +$1.53K ﹤0.01% 1372
2024
Q1
$93.5K Sell
1,546
-167
-10% -$10.1K ﹤0.01% 1363
2023
Q4
$45.8K Buy
1,713
+167
+11% +$4.47K ﹤0.01% 1354
2023
Q3
$93.5K Sell
1,546
-2,759
-64% -$167K ﹤0.01% 1363
2023
Q2
$439K Buy
4,305
+2,954
+219% +$301K 0.01% 919
2023
Q1
$239K Buy
1,351
+69
+5% +$12.2K 0.01% 1199
2022
Q4
$496K Buy
1,282
+55
+4% +$21.3K 0.01% 794
2022
Q3
$414K Buy
+1,227
New +$414K 0.01% 843